SCHEMBL2054545

SCHEMBL2054545

c1cc2n(n1)CCOC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21626282 0.88 DRD2 (0.34)
SCHEMBL23750847 0.81 DRD2 (0.35)
SCHEMBL10054568 0.68
SCHEMBL20861371 0.67 DRD2 (0.32)
SCHEMBL254839 0.67 LRRK2 (0.39)
SCHEMBL134980 0.67
SCHEMBL1027666 0.67
SCHEMBL22290756 0.65 LRRK2 (0.38)
SCHEMBL1392881 0.65 LRRK2 (0.38)
SCHEMBL30605066 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP claimed
EP-4514784-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-03-05 EP claimed
CN-119301106-A Allosteric benzopyrone inhibitors of phosphoinositide 3-kinase (PI 3K) for the treatment of disease 佩特拉制药公司 2025-01-10 CN claimed
US-20240182460-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION 2024-06-06 US claimed
US-20240174679-A1 HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2024-05-30 US claimed
WO-2024097172-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2024-05-10 WO claimed
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2024-01-18 US claimed
WO-2023212693-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2023-11-02 WO claimed
CN-116262739-A Nitrogen-containing aryl derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-06-16 CN claimed
CN-116171280-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-05-26 CN claimed
EP-4161494-A1 NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2023-04-12 EP claimed
US-20190082696-A1 METHOD FOR CONTROLLING PESTS OF PLANTS BASF SE (DE) 2019-03-21 US claimed
EP-3426042-A1 METHOD FOR CONTROLLING PESTS OF PLANTS BASF SE (DE) 2019-01-16 EP claimed
WO-2017153218-A1 METHOD FOR CONTROLLING PESTS OF PLANTS BASF SE (DE) 2017-09-14 WO claimed
JP-61286388-A None JP disclosed
US-12421225-B2 Heteroaromatic amide derivative and medicament containing the same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2025-09-23 US disclosed
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP disclosed
US-4929612-A ANTIBIOTICS, BACTERICIDES EISAI CO., LTD. (JP) 1990-05-29 US disclosed
EP-0287116-A2 Thiadiazolylacetamide cephem derivatives Eisai Co., Ltd. (JP) 1988-10-19 EP disclosed
JP-S61286388-A 3-CEPHEM DERIVATIVE EISAI CO LTD 1986-12-16 JP disclosed